Malignant Solid Tumor
Showing 1 - 25 of 38
Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)
Not yet recruiting
- Malignant Solid Tumor
- GEN1042
- +4 more
- (no location specified)
Sep 21, 2023
Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)
Not yet recruiting
- Cutaneous Tumor
- Malignant Solid Tumor
- JCXH-211 Injection
- (no location specified)
Feb 13, 2023
Advanced Solid Tumor, Malignant Solid Tumor Trial in Japan, United States (DS-7300a)
Recruiting
- Advanced Solid Tumor
- Malignant Solid Tumor
-
Los Angeles, California
- +21 more
Jan 5, 2023
Malignant Solid Tumor, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial in Worldwide (GEN1042, Pembrolizumab,
Recruiting
- Malignant Solid Tumor
- +5 more
- GEN1042
- +8 more
-
San Diego, California
- +27 more
Dec 24, 2022
Malignant Solid Tumor, Oncology Trial in Groningen (GEH200520 Injection / GEH200521 (18F) Injection - Part A, Dynamic and Static
Not yet recruiting
- Malignant Solid Tumor
- Oncology
- GEH200520 Injection / GEH200521 (18F) Injection - Part A
- +3 more
-
Groningen, NetherlandsUMC Groningen
Nov 17, 2022
Malignant Solid Tumor, Metastatic EphA2 Positive Cancer Trial in Heidelberg (DS-8895a 1 mg/kg, DS-8895a 3 mg/kg, DS-8895a 10
Completed
- Malignant Solid Tumor
- Metastatic EphA2 Positive Cancer
- DS-8895a 1 mg/kg
- +2 more
-
Heidelberg, Victoria, AustraliaAustin Health
Oct 3, 2022
Cutaneous Tumor, Malignant Solid Tumor Trial in Houston (JCXH-211)
Not yet recruiting
- Cutaneous Tumor
- Malignant Solid Tumor
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Sep 9, 2022
Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)
Recruiting
- Refractory Solid Tumor
- +4 more
- Atezolizumab
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 4, 2022
Malignant Solid Tumor Trial in Nashville (Ifetroban Sodium, Placebo)
Recruiting
- Malignant Solid Tumor
- Ifetroban Sodium
- Placebo
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jun 23, 2022
Malignant Solid Tumor Trial in Worldwide (BMS-986179, Nivolumab, rHuPH20)
Completed
- Malignant Solid Tumor
- BMS-986179
- +2 more
-
Chicago, Illinois
- +23 more
May 25, 2022
Malignant Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in Sacramento, New Brunswick (RRx-001, Irinotecan)
Terminated
- Malignant Solid Tumor
- +2 more
-
Sacramento, California
- +1 more
May 12, 2022
Malignant Solid Tumor Trial in Shanghai (Infusion of iNKT cells)
Completed
- Malignant Solid Tumor
- Infusion of iNKT cells
-
Shanghai, ChinaShanghai Public Health Clinical Center, Fudan University
May 6, 2022
Malignant Solid Tumor Trial in United States (ramucirumab (IMC-1121B), paclitaxel)
Completed
- Malignant Solid Tumor
- ramucirumab (IMC-1121B)
- paclitaxel
-
Ann Arbor, Michigan
- +5 more
Feb 14, 2022
Epithelial Tumors, Malignant, Malignant Solid Tumor Trial in Barcelona (NEXTGEN-TIL, Non-myeloablative Lymphodepletion (NMA-LD)
Recruiting
- Epithelial Tumors, Malignant
- Malignant Solid Tumor
- NEXTGEN-TIL
- +2 more
-
Barcelona, SpainVall d'Hebron Institute of Oncology
Nov 25, 2021
Malignant Solid Tumor, Pain Trial in San Francisco (Acupuncture, Pain Counseling)
Completed
- Malignant Solid Tumor
- Pain
- Acupuncture
- Pain Counseling
-
San Francisco, California
- +1 more
Oct 21, 2021
Malignant Solid Tumor Trial in Shanghai (Super circulating tumor infiltrating lymphocytes(ScTIL))
Recruiting
- Malignant Solid Tumor
- Super circulating tumor infiltrating lymphocytes(ScTIL)
-
Shanghai, Shanghai, China
- +1 more
Jul 14, 2021
Malignant Solid Tumor Trial in Belgium, United States (NKTR-102 145 mg/m2, NKTR-102 120 mg/m2, NKTR-102 95 mg/m2)
Completed
- Malignant Solid Tumor
- NKTR-102 145 mg/m2
- +3 more
-
Los Angeles, California
- +6 more
Jul 9, 2021
NSCLC, Malignant Solid Tumor Trial in United States (enzastaurin, erlotinib)
Completed
- Non-Small Cell Lung Cancer
- Malignant Solid Tumor
-
Los Angeles, California
- +9 more
Apr 20, 2021
Malignant Solid Tumor Trial in Beijing, Linyi (ASKB589 Injection)
Active, not recruiting
- Malignant Solid Tumor
- ASKB589 Injection
-
Beijing, Beijing, China
- +1 more
Feb 25, 2021
Malignant Solid Tumor Trial in Kanto Region (ONO-4538)
Completed
- Malignant Solid Tumor
- ONO-4538
-
Kanto Region, Kanto, Japan(unnamed)
Sep 15, 2020
Malignant Solid Tumor Trial in Leuven, Liège, Wilrijk (Olaparib Treatment A, Olaparib Treatment B, Olaparib Treatment C)
Completed
- Malignant Solid Tumor
- Olaparib Treatment A
- +3 more
-
Leuven, Belgium
- +2 more
Sep 30, 2020